retatrutide clinical trials south africa results trial ⭐️topline from TRIUMPH-1, a Phase 3 clinical trial Today's TRIUMPH-4 results are a

*Correspondence: Diva D

& Kemp, B

They can help you decide if the product is a safe choice for you

Published in 2016, the study showed that liraglutide reduced the risk of cardiovascular disease which is one of the most common causes of death in patients with type 2 diabetes

Notably, this study included broad range of GLP-1 drugs, including much older GLP-1s that have far lower anti-obesity, anti-craving, and anti-addictive effects: abiglutide (Eperzan, Tanzeum), dulaglutide (Trulicity), exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin, Lyxumia), semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro) Its possible that the associations that were found would be even stronger if the study had looked exclusively at semaglutide and tirzepatide, which are the current best-in-class options for weight loss